Pär-Ola Bendahl

Publication List Details

Period

2002 - 2009

Number

31

Co-Authors

Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels (2009)

Domanska, Katarina, Carlsson, Christina, Bendahl, Pär-Ola, Nilbert, Mef

Abstract Background Identification and adequate management of individuals at risk for hereditary nonpolyposis colorectal cancer (HNPCC) is crucial since surveillance programmes reduce morbidity and...

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck (2009)

Henriksson, Eva, Kjellén, Elisabeth, Baldetorp, Bo, Bendahl, Pär-Ola, Borg, Åke, Brun, Eva, ...

Abstract Background The survival of patients with locally advanced head and neck cancer is still poor, with 5-year survival rates of 24–35%. The identification of prognostic and predictive markers...

The CD44+/CD24-phenotype is enriched in basal-like breast tumors (2008)

Honeth, Gabriella, Bendahl, Pär-Ola, Ringnér, Markus, Saal, Lao H, Gruvberger-Saal, Sofia K, Lövgren, Kristina, ...

Abstract Introduction Human breast tumors are heterogeneous and consist of phenotypically diverse cells. Breast cancer cells with a CD44 + /CD24 - phenotype have been suggested to have...

Prognostic Impact of Array-based Genomic Profiles in Esophageal Squamous Cell Cancer (2008)

Carneiro, Ana, Isinger, Anna, Karlsson, Anna, Johansson, Jan, Jönsson, Göran, Bendahl, Pär-Ola, ...

Abstract Background Esophageal squamous cell carcinoma (ESCC) is a genetically complex tumor type and a major cause of cancer related mortality. Although distinct genetic alterations have been linked...

Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential (2007)

Francis, Princy, Namløs, Heidi, Müller, Christoph, Edén, Patrik, Fernebro, Josefin, Berner, Jeanne-Marie, ...

Abstract Background Soft tissue sarcoma (STS) diagnosis is challenging because of a multitude of histopathological subtypes, different genetic characteristics, and frequent intratumoral pleomorphism....

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers (2007)

Jumppanen, Mervi, Gruvberger-Saal, Sofia, Kauraniemi, Päivikki, Tanner, Minna, Bendahl, Pär-Ola, Lundin, Mikael, ...

Abstract Introduction Basal-phenotype or basal-like breast cancers are characterized by basal epithelium cytokeratin (CK5/14/17) expression, negative estrogen receptor (ER) status and distinct gene...

Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential (2007)

Francis, Princy, Namløs, Heidi Maria, Christoph Müller, Christoph, Edén, Patrik, Fernebro, Josefin, Berner, Jeanne-Marie, ...

Background Soft tissue sarcoma (STS) diagnosis is challenging because of a multitude of histopathological subtypes, different genetic characteristics, and frequent intratumoral pleomorphism....

Focus on the Tumour Periphery in MRI Evaluation of Soft Tissue Sarcoma: Infiltrative Growth Signifies Poor Prognosis (2006)

Josefin Fernebro, Marie Wiklund, Kjell Jonsson, Pär-Ola Bendahl, Anders Rydholm, Mef Nilbert, ...

Purpose. Infiltrative microscopical peripheral growth of soft tissue sarcomas (STS) has been shown to be of prognostic importance and preoperative risk stratification could individualize neoadjuvant...

Mapping of a Novel Ocular and Cutaneous Malignant Melanoma Susceptibility Locus to Chromosome 9q21.32 (2005)

Jönsson, Göran, Bendahl, Pär-Ola, Sandberg, Therese, Kurbasic, Azra, Staaf, Johan, Sunde, Lone, ...

An estimated 10% of all cutaneous malignant melanoma (CMM) cases are inherited, but the genetics of familial CMM are largely unknown. Ocular malignant melanoma (OMM), which is rare, may be associated...

Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. (2002)

Jönsson, Marzieh, Dejmek, Janna, Bendahl, Pär-Ola, Andersson, Tommy

Previous in vitro studies have implied that the Wnt-5a gene plays a role as a tumor suppressor. To explore the clinical relevance of this concept, 96 primary invasive breast carcinomas were stained...

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer. (2002)

Nordengren, Johanna, Fredstorp Lidebring, Margareta, Bendahl, Pär-Ola, Brünner, Nils, Fernö, Mårten, Högberg, Thomas, ...

Previous studies including various tumor types have shown different associations between tumor tissue levels of plasminogen activator inhibitor 2 (PAI-2) and patient survival. High tumor tissue...

Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. (2002)

Fernebro, Eva, Dictor, Michael, Bendahl, Pär-Ola, Fernö, Mårten, Nilbert, Mef

BACKGROUND: Immunohistochemical staining for tumor-associated proteins is widely used for the identification of novel prognostic markers. Recently, a tissue-conserving, high-throughput technique,...

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients (2002)

Look, Maxime P., Duffy, Michael J., Harbeck, Nadia, Christensen, Ib Jarle, Thomssen, Christoph, ...

Background: Urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) play essential roles in tumor invasion and metastasis. High levels of both uPA and PAI-1 are associated with poor...

Focus on the Tumour Periphery in MRI Evaluation of Soft Tissue Sarcoma: Infiltrative Growth Signifies Poor Prognosis

Fernebro, Josefin, Wiklund, Marie, Jonsson, Kjell, Bendahl, Pär-Ola, Rydholm, Anders, Nilbert, Mef, ...

Purpose. Infiltrative microscopical peripheral growth of soft tissue sarcomas (STS) has been shown to be of prognostic importance and preoperative risk stratification could individualize neoadjuvant...

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

Saal, Lao H., Johansson, Peter, Holm, Karolina, Gruvberger-Saal, Sofia K., She, Qing-Bai, Maurer, Matthew, ...

Pathway-specific therapy is the future of cancer management. The oncogenic phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in solid tumors; however, currently, no reliable test...